Antibiotic use in dentistry of bacteria from advanced caries. The first line of treatment is the removal of the source of inflammation or infection by local operative measures. Generally, the abscess can be eradicated through surgical drainage alone; however this is sometimes inadequate. Therefore, systemic antibiotic treatment may be required, but only if there is evidence of spreading infection. As the bacteria involved are known, antibiotic therapy selection can be specific, based on published susceptibilities. Penicillin in the form of amoxicillin is the most common antibiotic to use. However, 3% of the patient population is allergic to penicillin, so erythromycin is often used in
Antibiotic and antifungals treating life-threatening infections based on smaller clinical trials. The CDC will monitor the use of antibiotics and the emerging resistance, and publish the data. The FDA antibiotics labeling process, 'Susceptibility Test Interpretive Criteria for Microbial Organisms' or 'breakpoints', will provide accurate data to healthcare professionals. According to Allan Coukell, senior director for health programs at The Pew Charitable Trusts, "By allowing drug developers to rely on smaller datasets, and clarifying FDA's authority to tolerate a higher level of uncertainty for these drugs when making a risk/benefit calculation, ADAPT would make the clinical trials more feasible." Antibiotic An antibiotic